- Home
- QVCGA vs GDTC Comparison
QVCGA vs GDTC Comparison
Compare QVCGA & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QVCGA
- GDTC
- Stock Information
- Founded
- QVCGA 1991
- GDTC 2018
- Country
- QVCGA United States
- GDTC Singapore
- Employees
- QVCGA N/A
- GDTC N/A
- Industry
- QVCGA
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- QVCGA
- GDTC Health Care
- Exchange
- QVCGA NYSE
- GDTC Nasdaq
- Market Cap
- QVCGA 25.6M
- GDTC 21.5M
- IPO Year
- QVCGA N/A
- GDTC 2023
- Fundamental
- Price
- QVCGA $3.94
- GDTC $1.89
- Analyst Decision
- QVCGA
- GDTC Buy
- Analyst Count
- QVCGA 0
- GDTC 1
- Target Price
- QVCGA N/A
- GDTC $5.00
- AVG Volume (30 Days)
- QVCGA 657.9K
- GDTC 18.1K
- Earning Date
- QVCGA 08-07-2025
- GDTC 01-01-0001
- Dividend Yield
- QVCGA N/A
- GDTC N/A
- EPS Growth
- QVCGA N/A
- GDTC N/A
- EPS
- QVCGA N/A
- GDTC N/A
- Revenue
- QVCGA $9,800,000,000.00
- GDTC $368,838.00
- Revenue This Year
- QVCGA $2.89
- GDTC $5.37
- Revenue Next Year
- QVCGA $0.45
- GDTC N/A
- P/E Ratio
- QVCGA N/A
- GDTC N/A
- Revenue Growth
- QVCGA N/A
- GDTC N/A
- 52 Week Low
- QVCGA $2.27
- GDTC $1.20
- 52 Week High
- QVCGA $37.27
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- QVCGA N/A
- GDTC 37.08
- Support Level
- QVCGA N/A
- GDTC $1.85
- Resistance Level
- QVCGA N/A
- GDTC $1.95
- Average True Range (ATR)
- QVCGA 0.00
- GDTC 0.10
- MACD
- QVCGA 0.00
- GDTC -0.02
- Stochastic Oscillator
- QVCGA 0.00
- GDTC 28.00
About QVCGA QVC GROUP INC
QVC Group Inc is a live social shopping company with six retail brands QVC, HSN, Ballard Designs, Frontgate, Garnet Hill, Grandin Road, and other minority interests. QVC offers assortment of ,quality merchandise and classifies its products into six groups: home, apparel, beauty, accessories, electronics and jewelry. The company has three reportable segments: QxH, QVC International, and CBI. Majority of revenue is from Home products, from QxH segment. Company also operates in Japan, Germany and Other foreign countries.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.